Early Access — free while we kick the tires
EdgarHawk

ALL ALLSTATE CORP Insider Trading

Latest: Insider Sold $4.1M of Shares · May 2026

Multiple insiders have been active at ALLSTATE CORP (ALL): 8 distinct insiders account for 0 buy filings and 31 sell filings as of May 2026. Its highest-significance filing in the last 90 days: Rizzo Mario sold $4.1M, transaction dated May 2026.

31 filings analyzed · Latest 2026-05-04

Get alerts for ALL

Free Form 4 email alerts, scored for significance — see how.

Buys
0
Sells
31
Insiders
8
Direction
Net selling

ALLSTATE CORP leadership

Chair
Thomas J. Wilson — Chair, President and Chief Executive Officer

Historically, stocks have lagged the S&P 500 by a median ~3% over the 90 days after a low insider sell (n ≈ 1,162, 2024-2026). Past results don't predict the future. How we measure this ↗

May 2026
2026-05-04
low
18,578 shares
$4,064,866
@ $218.80
Significance 3

Non-officer Mario Rizzo exercises stock options and sells full position at near-52-week highs.

Mario Rizzo, who holds no officer, director, or major ownership stake at Allstate, exercised options and immediately liquidated the entire position in a single transaction. This is routine option monetization—when non-officers exercise, they typically sell to lock in gains rather than hold, so the back-to-back purchase-and-sell carries no signal about Rizzo's conviction in the company. The stock is trading near its 52-week high and has rallied solidly over the past few months, which is the typical environment that triggers option exercises. Allstate remains a financially healthy, profitable company with strong revenue and reasonable valuation metrics, but this filing reflects personal wealth management by a non-insider, not a statement about the stock's future direction. This is routine insider-activity noise.

March 2026
2026-03-17 10b5-1 Plan
medium
Chairman, President & CEO
16,807 shares
$3,510,938
@ $208.90
Significance 6

Allstate CEO Thomas Wilson sells 16,807 shares for $3,510,937.69 in 3 separate transactions, reducing stake 18.2%

On 2026-03-16, CEO Thomas J. Wilson executed 3 separate sales totaling 16,807 shares (16.8K shares) for $3,510,937.69 ($3.5M), reducing his direct holdings from 92,532 shares (92.5K shares) to 75,725 shares (75.7K shares)—an 18.2% reduction. The blended average transaction price was $208.90, near the current price of $207.27 (-3.7% from the 52-week high of $215.19). His cross-ticker track record shows 20 prior sells with a 90-day well-timed rate of 100.00%, indicating strong historical timing on sales, though measured outcomes at ALL specifically are not yet available for his 5 most recent trades at this ticker. The company reported strong recent fundamentals: $17.3B in latest quarterly revenue, $3.7B net income, 5.6% annual revenue growth, and a P/E of 3.84.

2026-03-04 10b5-1 Plan
medium
Chairman, President & CEO
16,807 shares
$3,567,576
@ $212.27
Significance 4

Chairman/President/CEO WILSON THOMAS J sells 16,807 shares for $3,567,576.03; post-sale holdings 92,532 shares (-15.4%)

WILSON THOMAS J executed three separate sales on 2026-03-02, disposing of 16,807 shares (16.8K shares) for $3,567,576.03 at a blended average price of $212.27, reducing his direct shareholdings by 15.4% from 109,339 to 92,532 shares. The stock currently trades at $214.18, near its 52-week high of $215.19 and up 6.7% over the prior 30 days, suggesting the sale occurred in a strong price environment. His cross-ticker track record shows 20 prior open-market sells with an average 30-day return of -1.1%, and at Allstate specifically his most recent comparable sales on 2026-02-02 posted 30-day gains of +7.8% and +7.3%, indicating prior sales at this ticker have not preceded declines. The fundamentals show a $17.3B-revenue enterprise with strong profitability ($3.7B net income) and 5.6% annual revenue growth, trading at a P/E of 3.97.

February 2026
2026-02-26 10b5-1 Plan
low
33,986 shares
$7,088,486
@ $208.57
Significance 3

Jesse E Merten sold 33,986 shares at $207.53–$210.44 for $7,088,485.57 (51.3% reduction); per 10b5-1 plan adopted 2025-11-07

Merten executed 4 separate sales on 2026-02-25 totaling 33,986 shares for $7,088,485.57, reducing his holdings from 66,287 to 32,301 shares. This substantial reduction represents a 51.3% decrease in his pre-transaction position. The transaction is executed under a pre-arranged 10b5-1 trading plan adopted on 2025-11-07, making it a scheduled, non-discretionary sale rather than a discretionary market decision. No pattern inference or timing signal can be drawn from this filing alone; the scheduled nature of the plan precludes characterization of the sale timing relative to market conditions.

2026-02-18 10b5-1 Plan
medium
Chairman, President & CEO
16,807 shares
$3,537,505
@ $210.48
Significance 5

Allstate CEO Wilson sells 16,807 shares (16.8K) for $3.5M on 2026-02-17 at $210.48 avg; post-sale holdings 109,339 shares

Thomas J Wilson, Chairman, President & CEO of Allstate Corp, executed 3 separate sales on 2026-02-17 totaling 16,807 shares (16.8K shares) for $3,537,504.72, reducing his holdings by 13.3% from 126,146 shares to 109,339 shares post-transaction. The blended average sale price of $210.48 reflects sales at $209.92, $210.72, and $211.50 across the three transactions. At the current price of $209.43, the stock is trading 2.7% below its 52-week high, while his cross-ticker track record shows a 90-day well-timed sell rate of 100.00% across 20 prior sales with an average 90-day return of -3.0%. However, his same-ticker trade history at Allstate reveals only one measurable prior sale at the 90-day mark (2026-01-12, down -0.5%), providing limited historical context specific to this security.

2026-02-04 10b5-1 Plan
medium
Chairman, President & CEO
16,807 shares
$3,373,324
@ $200.71
Significance 6

CEO Wilson Thomas J sold 16,807 shares for $3,373,323.92 across 4 transactions on 2026-02-02

Wilson Thomas J, Chairman, President & CEO of Allstate Corp, executed 4 separate sales on 2026-02-02, totaling 16,807 shares (16.8K shares) for $3,373,323.92 ($3.4M) at a blended average price of $200.71, reducing his holdings from 94,408 to 77,601 shares (-17.8% vs pre-transaction holdings). The sale occurred when the stock was trading near its recent peak, with current price at $207.12, which is -3.5% from the 52-week high of $214.65, and the stock has appreciated +0.8% over 30 days and +4.6% over 90 days. His cross-ticker track record shows 20 prior open-market sells with an average 90-day return of +5.0%, indicating his prior sales have been followed by stock appreciation; however, his same-ticker history at ALL consists of 5 recent sells on 2026-01-12, all with outcomes not yet measurable. The company's fundamentals show strong performance with annual revenue growth of +12.3%, though the P/E of 6.47 is notably compressed relative to the market.

January 2026
2026-01-13 10b5-1 Plan
low
Chairman, President & CEO
16,807 shares
$3,492,917
@ $207.83
Significance 4

Allstate CEO Wilson Thomas J sold 16,807 shares for $3,492,916.81 under pre-arranged 10b5-1 plan on 2026-01-12

Wilson Thomas J, Chairman, President & CEO of Allstate Corp, executed five separate sales totaling 16,807 shares (16.8K shares) for $3,492,916.81 ($3.5M) on 2026-01-12 at prices ranging from $205.68 to $209.99, with a blended average price of $207.83. This transaction reduced his holdings by 15.1% from 111,215 shares to 94,408 shares post-sale. The sales were part of a pre-arranged 10b5-1 trading plan adopted on 2025-06-27, indicating the transaction was scheduled rather than discretionary. Investors should note that 10b5-1 plans involve predetermined trading schedules established in advance and execute independent of current market conditions or company developments.

2026-01-08 10b5-1 Plan
medium
19,593 shares
$4,114,530
@ $210.00
Significance 5

Gupta Suren sold 19,593 shares of ALL at $210.00 on 2026-01-07 for $4,114,530.00; prior sales show mixed results, 0% well-timed at 90-day mark.

Gupta Suren sold 19,593 shares (19.6K shares) of Allstate at $210.00, reducing holdings by 16.3%. Reviewing his prior trades at Allstate specifically, his four measurable same-ticker sales showed positive 90-day returns of +11.6%, +10.8%, +10.2%, and +9.6%, meaning each sale preceded stock appreciation rather than decline—a 0% well-timed rate at the 90-day mark. His cross-ticker track record across 6 prior sales shows an average 90-day return of +10.2% with a well-timed rate of 0.00%, indicating a similar pattern of sales that did not precede price declines. The stock currently trades at $211.10, near 52-week highs of $214.65. The sale occurred at $210.00, about 0.5% below current levels, within the recent context of a +5.0% 30-day move and a +2.6% 90-day move. Fundamentals show strong performance: $17.3B latest-quarter revenue, $3.7B net income, and a P/E of 6.59.

2026-01-06 10b5-1 Plan
medium
Chairman, President & CEO
16,807 shares
$3,441,632
@ $204.77
Significance 5

ALLSTATE CEO Thomas Wilson sells 16,807 shares (16.8K) for $3,441,631.73 in 4 transactions on 2026-01-02

Thomas Wilson, Allstate's Chairman, President & CEO, executed 4 separate sales totaling 16,807 shares for $3,441,631.73 on 2026-01-02, reducing his holdings by 13.1% from 128,022 to 111,215 shares at a blended average price of $204.77. The stock currently trades at $207.92, within 3.1% of its 52-week high of $214.65. This filing follows three additional sales at the same ticker on 2025-12-15 and one on 2025-12-01, establishing a pattern of regular dispositions by the company's top executive. The cross-ticker track record shows 20 prior sells with a 100% well-timed rate at the 90-day mark (average 90d return of -3.1% after sales), though at Allstate specifically the prior measurable outcome (sell on 2025-12-01) showed a -2.4% 30-day return with no 90-day outcome yet available.

December 2025
2025-12-17 10b5-1 Plan
medium
Chairman, President & CEO
16,807 shares
$3,530,200
@ $210.04
Significance 6

ALL CEO Thomas J. Wilson sold 16,807 shares for $3,530,200.32 in 4 separate transactions on 2025-12-15 at blended average $210.04

Thomas J. Wilson, Chairman, President & CEO of Allstate, executed 4 separate sales totaling 16,807 shares for $3,530,200.32 at prices ranging from $208.35 to $210.96, reducing his holdings by 11.6% to 128,005 shares. The transactions occurred at $210.04 blended average against a current price of $209.08, near the 52-week midpoint and -2.6% from the 52-week high of $214.65. His cross-ticker track record shows a 100% well-timed rate on 20 prior sells with average 90-day return of -3.1%, but at Allstate specifically, his 5 prior measured trades have shown negative 30-day returns (-2.6%, -2.3%, -1.9%) with timing unable to be conclusively assessed. The multiple-transaction structure and scale of the reduction—representing over 11% of pre-transaction holdings—warrants monitoring alongside the company's strong fundamentals (P/E 6.53, $17.3B revenue, +12.3% annual growth, $3.7B net income).

More Insurance Carriers companies